HIV

Showing 1-10 of 16

05 Aug 1999  |  North America

United States HIV/AIDS Therapeutic Markets

 

 

USD 3,950.00

USD 2,962.50 save 25 %

15 Mar 2000  |  North America

United States HIV Diagnostic and Monitoring Markets

 

 

USD 3,950.00

USD 2,962.50 save 25 %

23 Dec 2002  |  North America

U.S. HIV Diagnostics and Monitoring Markets

 

The U.S. HIV Diagnostics and Monitoring Market report focuses on the dynamic and increasingly complex area of HIV diagnostics assays implemented to facilitate disease management. This report covers the Diagnostics, Viral Load Monitoring, Genotyping/Phenotyping, and CD4/CD8 Cell Monitoring segments of the market. This report provides an in-depth ana...

USD 2,450.00

USD 1,837.50 save 25 %

27 Jan 2003  |  North America

U.S. HIV/AIDS Therapies Markets

 

The U.S. HIV/AIDS Therapies Markets report covers the various antiretroviral (ARV) drugs that are currently available in the U.S. namely, NRTIs, PIs and NNRTIs. The report also covers the pipeline drugs from the existing and novel ARV categories, and the HIV vaccines pipeline. Frost & Sullivan Market Engineering Analysis, major market/technology tr...

USD 2,450.00

USD 1,837.50 save 25 %

This research service analyzes the changing dynamics within the global HIV therapeutics market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, analysis of growth opportuniters, and individual product forecasts and...

USD 3,950.00

USD 2,962.50 save 25 %

This research service analyzes the changing dynamics within the global HIV diagnostics and monitoring. Included in this research service are revenue forecasts, unit shipment, market and technology trends, major issues and challenges, analysis of growth opportunities, and competitive landscape. The market is segmented by - HIV Antibody Screening, ...

USD 3,950.00

USD 2,962.50 save 25 %

This research service discusses technology developments in the HIV drugs sector.

USD 4,950.00

USD 3,712.50 save 25 %

18 Apr 2009  |  Europe

European HIV/AIDS Therapeutics Markets

 

This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the ...

USD 4,950.00

USD 3,712.50 save 25 %

This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these market...

USD 4,950.00

USD 3,712.50 save 25 %

This research service provides the latest trends in HIV molecular diagnostics and discusses the prospects of future developments in this segment.

USD 4,950.00

USD 3,712.50 save 25 %

Showing 1-10 of 16